A Phase Ia, Dose Escalation Study of Humanized Anti-VEGF Monoclonal Antibody (Sevacizumab) Injection in Patients With Advanced or Metastatic Solid Tumors

PHASE1UnknownINTERVENTIONAL

Enrollment

Participants

Timeline

Start Date

April 30, 2013

Primary Completion Date

November 30, 2015

Study Completion Date

November 30, 2015

Conditions

Advanced Solid TumorsMetastatic Solid Tumors

Interventions

DRUG

Sevacizumab

Trial Locations (1)

RECRUITING

Fudan University Shanghai Cancer Center, Shanghai